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We report a rare case of metastatic malignant solitary fibrous tumor (SFT) that presented
with hypoglycemia because of insulin growth factor-2 production. Initial workup included
computed tomography imaging that revealed a large, partially necrotic liver mass, a
hypervascular pancreatic head lesion, and 2 renal lesions. Following hepatic resection,
pancreatic head resection and nephrectomy, all these lesions demonstrated pathological
findings that were consistent with SFT. The patient also had a history of an intracranial
mass that had been previously resected and treated with gamma knife therapy at an
outside institution, which was found to also be SFT. Six months after initial pancreatic
head resection, the patient developed a new lesion involving the pancreatic tail that was
found to represent recurrent metastatic SFT. This case emphasizes the highly aggressive
nature of extrapleural SFT, while rare, and the role of imaging in follow-up for disease
recurrence.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 39-year-old male presented with an episode of altered
mental status and was found to be hypoglycemic with blood
glucose levels of approximately 30 mg/dL. The patient had a
history of seizures with a low-grade brain tumor of unknown
etiology, status post-temporal lobe lesion resection approxi-
mately 10 years before this presentation and gamma knifeest Case Award, Gastroin
ared that no competing in
.A. Borhani).
Elsevier Inc. under copy
se (http://creativecommotherapy, all performed at an outside institution. Subsequent
workup for hypoglycemia included a contrast-enhanced
computed tomography (CT) scan of the abdomen and pelvis
after the intravenous administration of 125 cc of iopamidol-
370 (Isovue-370, Bracco Diagnostics, Princeton, NJ). CT scan
evaluation revealed a large, hypervascular abdominal mass
replacingmuch of the left hepatic lobe (Fig. 1). Also, 2 left renal
lesions (Fig. 2) and a hypervascular pancreatic head lesiontestinal Imaging at the American Institute of Radiologic Pathology
terests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e Axial (A) and coronal-reformatted (B) contrast-enhanced computed tomography (CT) images demonstrate a large,
heterogeneous enhancingmass that appears to arise from the left lateral segment of the liver with associatedmass effect on
the stomach.
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diagnosis was metastatic neuroendocrine tumor (possibly
insulinoma given the hypervascularity of the lesions and
history of hypoglycemia); metastatic fibrolamellar hepatocel-
lular carcinoma was also considered in the differential
diagnosis.Fig. 2 e Axial and coronal contrast-enhanced CT images (A and
(arrow) measuring up to 3.9 cm. There is also a smaller inferiorSoon after, an exploratory laparotomywas performedwith
left hepatic lobectomy along with enucleation of pancreatic
head lesion and abdominal lymph node dissections. Surgical
evaluation revealed a large upper abdominal mass arising
from the left hepatic lobe that was partially adherent to the
left diaphragm and abutting the spleen. EnlargedB) demonstrate an enhancing left upper pole renal mass
pole lesion located within the left renal cortex (C).
Fig. 3 e Axial contrast-enhanced CT image demonstrates a
hyperenhancing lesion (arrow) within the pancreatic head
in addition to the large lateral segment hepatic mass.
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pancreatic head lesion were also identified on palpation and
then resected.
On gross examination (Fig. 4), the large left hepatic lobe
massmeasured 20 18 15 cm and demonstrated focal areas
of hemorrhage. Histopathological evaluation revealed
spindle-shaped neoplastic cells growing in small nests
surrounding the small vessels with associated luminal
compression (Fig. 4). Approximately 4 mitoses per 10 high-
powered fields (4/10 hpf) and increased cellularity were seen,
suggesting a more aggressive tumor behavior. Tumor cells
were positive to collagen 4, vimentin, calponin, Bcl-2 and
STAT-6 (Fig. 4B). Histologic changes and immunophenotype of
the resected pancreatic head mass appeared similar to the
liver mass (Fig. 5) representing “hemangiopericytoma-like”
solitary fibrous tumor (SFT).
Because of an interval increase in the size of renal lesions
approximately 3 months after resection of the hepatic and
pancreatic lesions, the patient underwent surgery for biopsy
and possible nephrectomy with a concern that the renal
lesions might represent renal cell carcinoma rather than SFT
metastases. A rock-hard white-colored exophytic left upperFig. 4 e A large liver mass is demonstrated on gross pathology
areas of necrosis and hemorrhage. Standard hematoxylin and
spindle-shaped cells and a high mitotic index (B). STAT-6 and v
Findings were consistent with solitary fibrous tumor.pole lesion was identified externally and the smaller inferior
pole lesion was appreciated on palpation. Because of the
multiplicity of the lesions, it was decided to proceed with
radical nephrectomy.
The gross examination of the left kidney demonstrated a
bulging encapsulated lesion in the superior pole of the left
kidney abutting Gerota fascia (Fig. 6). Both superior pole and
inferior pole renal lesions showed morphologic and immu-
nophenotypic findings similar to the resected liver and
pancreatic lesions consistent with multifocal SFT.
Given the patient's history of a low-grade brain tumor,
there was a concern that the previously treated intracranial
lesion could have, in fact, represented a SFT. The prior brain
magnetic resonance imaging (MRI) findings from the outside
hospital were not, as would be expected, consistent with a
low-grade neoplasm as prior pathology reports had suggested.
There was avid enhancement of a lobulated, likely extra-axial
left temporal lobe lesion with associated mass effect and
vasogenic edema (Fig. 7). Our pathology department reviewed
the previously obtained intracranial tumor specimen from the
prior left temporal lobe lesion resection (Fig. 7). A spindle-
shaped neoplasm was seen with neoplastic cells growing in
small nests (Fig. 7). Neoplastic cells were monomorphic with
thin-walled anastomosing vessels. Therefore, both imaging
and pathology reviews suggested that the patient's previously
treated “low-grade brain tumor” was actually a SFT.
Approximately 6 months after the initial resection of
hepatic and pancreatic head lesions, a routine follow-up
contrast-enhanced CT examination was performed (Fig. 8),
which observed a new 1.0 cm hypervascular pancreatic tail
lesion. Spleen-preserving distal pancreatectomy was
performed (Fig. 8), and pathology confirmed suspected meta-
static SFT. The patient continues to be followed with clinical
and imaging follow-up. His hypoglycemia has resolved
following partial pancreatectomy.Discussion
SFTs, formerly termed hemangiopericytoma, are rare
mesenchymal tumors that usually present as slowly growing
painless masses in middle age without any sex predilection.(A) following left hepatic lobectomy. The mass contained
eosin (H&E) stains with magnification observed
imentin immunohistochemical stains were positive.
Fig. 5 e Microscopic examination of the hypervascular
pancreatic lesion demonstrated similar appearance to the
large liver mass with spindle-shaped cells and
immunohistochemical staining consistent with solitary
fibrous tumor involving the pancreas. The tumor is seen
infiltrating normal pancreatic tissue (P).
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sion of adjacent structures. Theymay arise from any location,
but SFTs are thought tomost commonly involve the pleura [1].
Extrapleural SFTs were only recognized pathologically in the
last 2 decades and may represent more cases than previously
recognized [2]. The extrapleural SFTs more commonly involve
the liver [3]. Other sites of involvement include the perito-
neum, kidneys, orbits, meninges, and parotid glands [1,2,4e7].
SFT is generally associated with good prognosis with an
overall 5-year survival of 84%-89% [2,8]. However, approxi-
mately 26% and 45% of cases develop metastases at 5 and 10
years, respectively [2]. The markedly aggressive nature of
some extrathoracic SFTs has been increasingly recognized
over the past 2 decades with approximately one-tenth of
SFTs demonstrating malignant pathology and metastasis
[9e12]. Larger tumors with higher mitotic indices demon-
strate much greater risk of metastases and poorer outcomes
[2,8]. Our case exemplifies a particularly aggressive form of
SFT with intracranial, pancreatic, hepatic, and renal
involvement as well as subsequent recurrence with aFig. 6 e Split gross pathological specimen (A) following radical
within the upper pole of the kidney. The lower pole lesion was
examination was similar revealing spindle-shaped neoplastic cpancreatic tail metastasis less than 1 year after initial
surgical resection of abdominal lesions.
Some SFTs present with paraneoplastic syndromes
including hypoglycemia related to the production of insulin-
like growth factor 2 (IGF-2), termed DoegeePotter syndrome,
that may be confused for symptoms seen with neuroendo-
crine tumors as was initially suspected in our case [13].
DoegeePotter syndrome is encountered in less than 5% of SFT
cases and is reported in rare cases of SFT involving the liver
[13e15]. Patients who have liver involvement and hypoglyce-
mia, as in our case and others, appear to have more grave
coursewith higher rate ofmetastases and recurrence; in these
patients, serum IGF-2 may be helpful in assessing for recur-
rence in addition to surveillance imaging [15].
The etiology of SFT is attributed to mutations of the NAB2
and STAT6 genes located on chromosomal region 12q13 [16].
SFTs are generally well-circumscribed, partially encapsulated
tumors. When aggressive, areas of necrosis and hemorrhage
may be seen, as in our example. On histology, spindle-shaped
or ovoid cells are seenwith varyingmitotic rates depending on
aggressiveness. Classically described findings include
hemangiopericytoma-like vessels and prominent stromal
collagen. These lesions strongly express vimentin [1]. On
immunohistochemistry, STAT-6 immunoreactivity in the
nuclei is a sensitive and specific indicator of SFT. All the
sampled lesions in this case demonstrated pathology findings
consistent with SFT including STAT-6 staining [17].
SFTs may present in a variety of locations, usually as a
single well-circumscribed largemasswithin the abdomen and
pelvis [7,18]. They demonstrate avid enhancement on arterial
phase imaging that increases progressively during venous and
delayed phases [19]. There may be areas of necrosis that are
hypoattenuating on CT scan and do not enhance, as noted in
the large hepatic mass in our patient. Calcification within
these masses, sometimes quite large, have also been reported
[7].
The lesions are described to be hypo- to isointense on
T1-weighted MRI and showing heterogeneous T2 hyper-
intensity [18,19]. Sonographic evaluation demonstrates
heterogeneous echotexture with internal vascularity on
Doppler examination [7]. Echogenicity is generally increased
compared with the normal liver [7]. Large vessels may be seennephrectomy demonstrates a tan solid soft tissue lesion
identified on gross examination as well (B). Microscopic
ells consistent with solitary fibrous tumor.
Fig. 7 e Brain MRI (A-D) performed in this patient more than 10 years before presentation had demonstrated a tumor
(arrows) in the left temporal lobe region that was thought to represent a low-grade glial tumor on pathology at the time of
resection. Axial FLAIR (A) and coronal T2-weighted (B) images show a peripherally hypointense and internally hyperintense
extra-axial lesion near the posteroinferior left temporal lobe with associatedmass effect and vasogenic edema. Axial (C) and
sagittal (D) postcontrast T1-weighted images demonstrate avid enhancement of this lobulated extra-axial lesion. Secondary
pathological review of the previously obtained specimen (E) revealed spindle-shaped cells with moderate pleomorphism
that was consistent with solitary fibrous tumor.
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Fig. 8 e Six months after surgical resection of the large hepatic mass and pancreatic head resection, a routine follow-up CT
examination was performed that showed a new enhancing pancreatic tail mass (arrow) (A). The pancreatic tail lesion was
resected with spleen-preserving distal pancreatectomy (B), with pathology confirming recurrent metastatic solitary fibrous
tumor.
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e76within these tumors, which are seen as areas of flow-related
signal loss on spin-echo MRI [7]. Associated imaging findings
may be seen related to mass effect within the abdomen such
as compression of bowel or the urinary bladder with second-
ary findings of obstruction.
The presentation of this casewas unusual for SFT given the
simultaneous presence of hepatic, pancreatic, and renal le-
sions (also with a history of brain tumor of unknown etiology
later shown to be SFT), as well as later recurrence with a new
pancreatic tail lesion. This hepatic mass raised the possibility
of an atypical presentation of hepatocellular carcinoma, but
this was felt to be unusual given the clinical presentation,
patient age, and the absence of underlying liver disease.
Alternatively, the imaging findings of a hypervascular
pancreatic lesion suggested that this might represent a met-
astatic neuroendocrine tumor especially in conjunction with
the patient's clinical presentation with hypoglycemia. The
renal lesions were initially felt to represent metastatic disease
over primary renal cell carcinoma, but interval enlargement of
the lesions was concerning for a more aggressive neoplasm
and radical nephrectomywas performed, revealingmultifocal
SFT. Pattern of enhancement was very atypical for lymphoid
tumor. Sarcoma could also be considered within the differ-
ential diagnosis although abdominal sarcomas (liposarcoma
or leiomyosarcoma) commonly arise from retroperitoneum.
Ultimately, resection is required and while there are
some overlapping histological features, SFT may be differen-
tiated with the presence of spindle-shaped cells,
hemangiopericytoma-like vessels, and most importantly,
STAT6 immunopositivity [17].
This case highlights the utility of review of prior imaging
studies and pathology specimens in cases of multiorgan tu-
moral involvement. As the aggressive nature of extrathoracic
SFTs has been underestimated in the past, we emphasize the
importance of continued clinical surveillance in patients
diagnosed with SFT, even with benign pathology and no me-
tastases on initial presentation [12]. The clinical utility of
adjunctive treatment is poorly understood for these rare SFTs,
and further investigation is needed to ascertain the role
of chemotherapy or radiation therapy following tumor
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